Healthcare
Neogen Corporation(NEOG)
Live Price
Offline$8.92
-4.19% today
1Y Change
+81.31%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $2.07B
- Revenue Growth
- -3.2%
- EPS Growth
- -11463.2%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Neogen Corporation (NEOG) is a Healthcare stock with a market cap of $2.07B and listed on NASDAQ. The stock last traded around $8.92 and up 81.3% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of -3.2%, EPS growth of -11463.2%, a dividend yield of 0.0%. What stands out right now is revenue -3.2%, EPS -11463.2%, free cash flow +39.1% with operating margin -3.7% and ROIC -1.0%. Valuation is more restrained than many high-expectation growth names at price/sales 2.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines NEOG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-3.2% vs +7.6% peer median
Operating Margin
Below sector median
-3.7% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 9, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -3.2% and EPS is at -11463.2%, with operating margin around -3.7%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 28, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -7.7% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 9, 2026 | โ | -6.2% | -8.0% | -7.9% |
2026 Jan 8, 2026 | +42.9% | -0.9% | -2.6% | +11.2% |
2025 Oct 9, 2025 | +154.1% | -10.9% | -12.5% | -11.8% |
Benchmark Edge
NEOG vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NEOG
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NEOG Max Drawdown
-27.71%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NEOG and SPY.
Company Overview
Neogen Corporation
NASDAQ Global Select
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
- Leadership
- Mikhael Nassif
- IPO Date
- Aug 23, 1989
- Employees
- 2.9k
- Street Address
- 620 Lesher Place
- Mailing
- Lansing, MI, 48912
- Region
- Lansing, MI, US
- Reporting Currency
- USD
- Investor Line
- 517 372 9200
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 2.4
- Price/Book
- 1.0
Growth
- Revenue
- -3.2%
- EPS
- -11463.2%
- Free Cash Flow
- +39.1%
Profitability
- Gross Margin
- 39.9%
- Operating Margin
- -3.7%
- Net Margin
- -69.9%
- ROE
- -29.0%
- ROIC
- -1.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 3.92
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.